Ocugen Stock: Buy Or Sell Depends On COVID-19 Trial Approval
FG Trade/E+ via Getty Images Introduction I give Ocugen, Inc. (NASDAQ:OCGN) a hold rating. Ocugen is very far along in ...
Read moreTag: Ocugen
Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors
Ocugen: WHO Approval For Covaxin Is Potentially A Red Herring For Investors
Read more
Reuters exclusively reports Ocugen plans to sell 100 million Indian vaccine doses in U.S.
Health15 March 2021, 7:46 pm. 1 minute Reuters exclusively reported that U.S.-based biopharmaceutical firm Ocugen Inc plans to sell 100 million doses ...
Read more
